Fortress Biotech (FBIO) Stock: Buy, Sell, or Hold?
FBIO - Fortress Biotech, Inc.
$2.03
-0.04 (-1.93%)
▼
5d:
-10.96%
30d:
-25.64%
90d:
-31.19%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When FBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: FBIO is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: FBIO is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: FBIO is currently trading at $2.03, which is considered oversold relative to its 30-day fair value range of $2.27 to $2.74. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.0) compared to its historical average (136.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, FBIO is in a uptrend. The price is currently testing key support at $2.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FBIO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.00 (+146.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, FBIO is in a uptrend. The price is currently testing key support at $2.01. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: FBIO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (24th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.00 (+146.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.27 -
$2.74
Company Quality Score
43/100
(HOLD)
Options IV Signal
24th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
69.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 24th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 146.3% below Wall St target ($5.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.27 -
$2.74
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.21
(10.3%)
Support & Resistance Levels
Support Level
$2.01
Resistance Level
$2.52
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.03
Wall Street Target
$5.00
(+146.3%)
Revenue Growth (YoY)
14.0%
Profit Margin
163.3%
PE vs Historical
-2.0 vs 136.2
CHEAP
Share & Embed Analysis
Last updated: October 03, 2026 2:42 PM ET
Data refreshes hourly during market hours. Next update: 3:42 PM
Data refreshes hourly during market hours. Next update: 3:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 68 BUY |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$107 | 67 BUY |
|
ARCT
Arcturus Therapeutics Ho… |
STRONG BUY
11 analysts |
$23 | 57 HOLD |
